Subsequently, the drugs are released and exert cytotoxic effect killing these cancer cells. These findings indicate that the obtained complexes can be attractive candidates for delivery of cationic drugs to tumors.
INTRODUCTION
A very special class of drug delivery systems based on block and graft copolymers containing ionic and non-ionic water-soluble segments ("block ionomers") was proposed in mid-90-ies [1] [2] [3] [4] . Such drug delivery systems are spontaneously formed in aqueous solutions upon electrostatic binding of block ionomer with oppositely charged molecules. The resulting complexes represent micelle-like particles termed "polyion complex micelles" [5] [6] [7] , or "block ionomer complexes" (BICs) [8, 9] . They have attracted great attention in various applications for delivery of low molecular mass drugs [10] [11] [12] [13] , proteins [14, 15] , polynucleotides (antisense oligonucleotides [16, 17] , plasmid DNA [18, 19] , siRNA [20, 21] ) and imaging agents [22, 23] . For example, due to extended blood circulation and ability to circumvent renal excretion, known as the "enhanced permeability and retention (EPR) effect" [24, 25] , BICs loaded with anticancer drugs exhibit preferential accumulation and delivery of their cargos to solid tumors [26] .
A special class of BICs was previously prepared by reacting block ionomers with surfactants of opposite charge, resulting in the spontaneous formation of the nanomaterials, which differ in sizes and morphologies, such as micelles and vesicles [27] [28] [29] [30] [31] [32] [33] [34] . These materials contain a hydrophobic core formed by the surfactant tail groups and a hydrophilic shell formed by nonionic chains of the block copolymer (for example by PEG). These BICs can incorporate charged surfactant drugs, such as retinoic acid that binds to the polyelectrolyte chains, as well as hydrophobic non-charged drugs that solubilize in the hydrophobic domains formed by surfactant tail groups [35] . They display an ability to respond to the changes in the environmental parameters such as pH and ionic strength and can be designed to release drugs triggered by the environment in the target cell [36] . The simplicity of design and availability of diverse surfactant components for preparation of such BICs makes them quite attractive for development of carriers for drug delivery. 
Fluorescence measurements
Fluorescence spectra and intensity measurements were carried out using Fluorolog3
(Horiba Jobin Yvon, France). Pyrene solubilization method was used to detect the onset of surfactant aggregation [40, 41] . The known amounts of pyrene in acetone were added to empty vials, followed by acetone evaporation. Solutions of surfactants or surfactant/PEG-b-PVBP mixture in phosphate buffer (10 mM, pH7.0) containing 5 vol% of methanol were added to the vials and kept overnight under constant stirring at room temperature. Pyrene concentration in the final solution was 0.95 µM. Pyrene fluorescence spectra were recorded at λ ex = 336 nm, λ em = 340 -460 nm, and bandwidth of 2.5 nm for excitation and emission. All measurements were performed at room temperature.
Size and ζ-potential measurements
Effective mobility and z-averaged hydrodynamic diameters of the BICs were determined by dynamic light scattering (DLS) using ZetasizerNano ZS (Malvern Instruments, U.K.) equipped with a He-Ne laser that operated at a wavelength of 635 nm. Measurements were performed at a detection angle of 173º at room temperature. ζ-potential of the particles was calculated from the electrophoretic mobility value using Smoluchowski equation. Software provided by the manufacturer which employs cumulants analysis and non-negatively constrained least-squares particle size distribution analysis routines was used to analyze the size of the particles, polydispersity indices (PDI), and ζ-potential. The mean values were calculated from the measurements performed at least in triplicate.
Atomic Force Microscopy (AFM) measurements
AFM imaging was performed in air using a Multimode NanoScope IV system (Veeco, Santa Barbara, CA) operating in a tapping mode. The unbound surfactant and large aggregates were separated from the BICs solutions using NAP column (GE Healthcare, US) and 0. Absorption was measured at 570 nm in a microplate reader (SpectraMax M5, Molecular Devices Co., US) using wells without cells as blanks. All measurements were taken eight times.
Confocal microscopy on live cell
Cellular uptake of DOX/PEG-b-PVBP BIC was characterized by live cell confocal imaging using Carl Zeiss LSM 510 Meta Confocal microscope (Peabody, MA). MCF-7 cells were plated in live cell chambers (Fischer Scientific, Waltham, MA) and after two days (37 ºC, 5 % CO 2 )
exposed to DOX/PEG-b-PVBP BIC for 30 min, followed by incubation with Lysotracker Green for 5 min. Finally, cells were washed and kept in complete media for confocal imaging.
RESULTS AND DISCUSSION Formation of BIC as a function of surfactant concentrations
The interaction between PEG-b-PVBP and various cationic surfactants was characterized by steady-state fluorescence using pyrene as a probe. The ratio of intensities of the first and third highest energy emission peaks in the pyrene spectrum (I 1 /I 3 ratio) correlates with the polarity of the immediate environment of the pyrene probe. In aqueous solution the I 1 /I 3 ratio is about 1.7-1.9
while in a nonpolar solvent such as hexane it is about 0.6 [41] . The interaction between polyions and oppositely charged surfactants is a cooperative process in which the surfactant ionic head groups bind to the polyion units while the surfactant alkyl tails segregate into a hydrophobic microphase. This process is characterized by "critical association concentration" (cac), corresponding to the onset of surfactant binding to the polymer. As seen in (Table 1) . This suggested that PEG-b-PVBP enhanced the surfactant aggregation as a result of electrostatic coupling of the surfactant head groups and polyion repeating units.
Characterization of BICs
The surfactant/PEG-b-PVBP BICs were characterized on a macroscopic level by photon correlation spectroscopy and laser microelectrophoresis technique at various compositions of the mixture. It is also important to note that there were little if any differences in ζ-values for all BICs at different pH, from pH5.0 to pH8.0 (Figure 1 (c) ). In all cases, ζ-values were negative at Z < 1.
Therefore, only a part of PVBP chain was neutralized by the surfactant under these conditions, while the remaining ionized phosphonate groups provided for the net negative charge of the particles. As Z value increased the value of ζ-potential is also increased due to progressive Supplementary Information, Figure S3 ). It is likely that the aliphatic tails of the surfactant inserted into the hydrophobic domains of the BIC while the ionic head groups were exposed to water. Similar behavior was previously described for regular BIC of various block copolymers and oppositely charged surfactants [9, 42] . However, the less hydrophobic surfactants with shorter aliphatic groups (DTAB and C12Py) exhibited reduced ability for incorporation into the BICs at the surfactant excess. In these cases the net charge of the respectively. It is reported that micelle size and its distribution tend to decrease during drying process [38] . Thus, smaller size and size distribution of BICs in AFM analysis are probably due to drying process on mica. 
Effect of salt concentration on BICs
Addition of low molecular weight of salts to complexes of electrolytes with oppositely charged surfactants usually leads to destabilization of the salt bonds. 
Preparation of DOX and PEG-b-PVBP complex
We evaluated a possibility to immobilize a cationic anti-cancer drug (DOX, pKa = 8. (Figure 4(a) ). At Z < 1 ζ-potential of the BICs was increases as the concentration of the added DOX (Figure 4(b) ). Nearly all added DOX molecules were incorporated into BIC since practically no unbound DOX was detected in the solution at 0.1 ≤ Z ≤ 1.0 ( Supplementary Information, Figure S5 ). 
Release of DOX from BIC
The DOX release from the DOX/PEG-b-PVBP BIC was pH-dependent with the rate of the release being much faster at acidic pH5.5 than at neutral pH7.4 ( Figure 6 ). At pH7. 
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